BOHD (psychedelic)

BOHD
Names
	Preferred IUPAC name 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethan-1-ol
	Other names 4-Methyl-2,5-dimethoxy-beta-hydroxyphenethylamine; 2-(4-Methyl-2,5-dimethoxyphenyl)ethan-beta-hydroxyamine
Identifiers
CAS Number	29348-16-1 ;
3D model (JSmol)	Interactive image;
ChemSpider	21106263 ;
PubChem CID	44719489;
UNII	QX20VMP285 ;
CompTox Dashboard (EPA)	DTXSID70660352 ;
	InChI InChI=1S/C11H17NO3/c1-7-4-11(15-3)8(9(13)6-12)5-10(7)14-2/h4-5,9,13H,6,12H2,1-3H3 Key: WCURBUJUIMRCCJ-UHFFFAOYSA-N ; InChI=1/C11H17NO3/c1-7-4-11(15-3)8(9(13)6-12)5-10(7)14-2/h4-5,9,13H,6,12H2,1-3H3 Key: WCURBUJUIMRCCJ-UHFFFAOYAU;
	SMILES COc1cc(C)c(cc1C(O)CN)OC;
Properties
Chemical formula	C11H17NO3
Molar mass	211.261 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

BOHD (4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-hydroxy derivative of 2C-D. BOHD was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 50 mg, and the duration unknown.^[1] BOHD produces a marked drop in blood pressure.^[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOHD.